5-Amino-1MQ 10mg — Vial Spec, Reconstitution Math & COA

5-Amino-1MQ 10mg Vial Specification & Laboratory Overview

A 10mg vial of 5-Amino-1MQ contains 10 milligrams of lyophilized 5-amino-1-methylquinolinium fluoride, a synthetic small-molecule membrane-permeable inhibitor of the cytosolic enzyme nicotinamide N-methyltransferase (NNMT). In biochemical research, this 10mg mass specification is routinely selected by academic and institutional laboratories conducting high-throughput cell culture assays, multi-well microplate titrations, or extended in vivo rodent protocols where higher stock concentrations are required to minimize total working volume additions.

While 10mg represents a standard reference quantity for high-density assay runs, PX1 Research maintains stock offerings in multiple standardized sizes to accommodate diverse experimental scale requirements. For instance, laboratories running lower-volume assays or single-plate pilot studies often utilize our 5-Amino-1MQ 5mg format. Researchers can evaluate our full catalog of high-purity compounds by visiting our all research peptides inventory hub. Regardless of fill mass, all 5-Amino-1MQ preparations provided by PX1 Research are synthesized in USA-based facilities, undergo rigorous analytical verification, and are designated strictly for laboratory research use only.

Reconstitution Math & Volumetric Calculations (10mg Mass)

Accurate reconstitution of 5-Amino-1MQ requires careful consideration of both the final target molarity/concentration and the solubility parameters of the compound in the chosen diluent. Depending on the research model (e.g., cell-free enzymatic assays, cell culture medium dosing, or animal model administration), researchers may elect to reconstitute using sterile bacteriostatic water, phosphate-buffered saline (PBS), or a low-percentage dimethyl sulfoxide (DMSO) solvent matrix for non-aqueous stock preparations.

When preparing stock solutions from a 10mg lyophilized cake, the following volumetric calculations yield standard working concentrations:

• 1.0 mL Diluent Addition: 10 mg / 1.0 mL = 10.0 mg/mL concentration (10,000 µg/mL). • 2.0 mL Diluent Addition: 10 mg / 2.0 mL = 5.0 mg/mL concentration (5,000 µg/mL). • 3.0 mL Diluent Addition: 10 mg / 3.0 mL = 3.33 mg/mL concentration (3,333 µg/mL). • 5.0 mL Diluent Addition: 10 mg / 5.0 mL = 2.0 mg/mL concentration (2,000 µg/mL).

To convert these mass concentrations to micromolar (µM) values for in vitro receptor or enzyme kinetics assays, calculate using the molecular weight of 5-amino-1-methylquinolinium (MW ≈ 159.21 g/mol for the cation, adjusted for salt form mass). Researchers needing to automate microtiter diluent volumes or verify multi-step serial dilutions can utilize our online reconstitution calculator tool to streamline bench calculations.

Aliquot Planning, Handling, and Long-Term Stability Protocols

Lyophilized 5-Amino-1MQ exhibits superior thermodynamic stability when stored sealed under inert atmosphere at -20°C to -80°C, protected from direct light exposure and ambient moisture. Upon reconstitution, small-molecule inhibitors in solution can undergo gradual chemical degradation or concentration loss due to evaporation and wall-adsorption if not handled according to standardized laboratory protocols.

To preserve maximal enzymatic activity and prevent degradation through repeated freeze-thaw cycles, reconstitute the 10mg cake under a laminar flow hood using sterile technique. Immediately divide the primary working solution into single-use micro-aliquots (e.g., 50 µL to 200 µL) in high-recovery polypropylene microcentrifuge tubes.

Store aliquoted stock solutions at -80°C for long-term study series or at 4°C for short-term use completed within 48 to 72 hours (depending on diluent buffer stability). Never subject reconstituted stock solutions to more than two freeze-thaw cycles, as crystal formation and thermal stress can destabilize active molecule stoichiometry.

Enzymatic Target: Mechanism of NNMT Inhibition

Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme predominantly expressed in metabolic tissues, including white adipose tissue (WAT), liver parenchyma, and skeletal muscle. NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH).

By functioning as a membrane-permeable, selective transition-state inhibitor of NNMT, 5-Amino-1MQ directly blocks this methyl transfer pathway. In cell-free and cell-based models, inhibition of NNMT prevents the irreversible methyl-tagging and clearance of nicotinamide. Because nicotinamide serves as a primary precursor in the salvage pathway for nicotinamide adenine dinucleotide (NAD+) biosynthesis, inhibiting NNMT preserves cellular NAM pools for salvage into NAD+.

Researchers investigating metabolic pathways, epigenetic histone methylation, and cellular bioenergetics frequently utilize 5-Amino-1MQ to modulate this fundamental enzymatic junction. Additional biochemical mechanisms and signaling pathway data are archived within our research library.

Preclinical Insights: NAD+ salvage, Sirtuins, and Mitochondrial Output

In vitro data and rodent model assays indicate that NNMT overexpression correlates strongly with reduced intracellular NAD+ availability, diminished mitochondrial respiration, and increased adipocyte lipid storage. When NNMT is selectively inhibited by 5-Amino-1MQ in preclinical research models, several cascade mechanisms are observed:

1. Intracellular NAD+ Pool Restoration: Preclinical studies report that blocking the conversion of NAM to MNA increases cellular concentrations of NAD+, effectively enhancing the intracellular NAD+/NADH ratio.

2. Activation of Sirtuin Pathways: Downstream of elevated NAD+ availability, NAD+-dependent deacetylases such as SIRT1 and SIRT3 exhibit increased enzymatic activity. SIRT1 activation promotes PGC-1α upregulation, a master regulator of mitochondrial biogenesis.

3. Enhancement of Oxygen Consumption Rates (OCR): Extracellular flux analysis in cell culture models demonstrates that 5-Amino-1MQ administration yields measurable increases in baseline and maximal mitochondrial respiration rates in targeted adipocytes and myoblasts.

4. Modulation of Methyl Donor Pools: By sparing S-adenosylmethionine (SAM) from consumption by NNMT, 5-Amino-1MQ alters the SAM/SAH ratio, providing an experimental framework for studying epigenetic regulation and histone methylation dynamics in metabolic disease models.

Adipocyte Remodeling and Skeletal Muscle Bioenergetics

In preclinical metabolic disease models—particularly diet-induced obesity (DIO) rodent cohorts—NNMT expression is markedly upregulated in white adipose tissue. Research protocols testing 5-Amino-1MQ in DIO mice have observed altered adipocyte morphology, characterized by reduced adipocyte volume, decreased intracellular triglyceride storage, and enhanced basal metabolic rate without altering food intake.

Furthermore, in skeletal muscle research, 5-Amino-1MQ is evaluated for its role in muscle fiber regeneration and mitochondrial function. In vitro studies on injured or aging myoblasts indicate that NNMT inhibition promotes satellite cell proliferation and enhances oxidative phosphorylation capacities in contracting muscle fibers. These findings make 5-Amino-1MQ a primary compound of interest across metabolic, sarcopenia, and exercise physiology research paradigms.

Quality Assurance, Purity Analysis & Lot-Matched COA Verification

High-throughput screening and quantitative biochemical research require absolute chemical purity, precise molecular mass verification, and freedom from cellular toxins. PX1 Research enforces strict quality assurance protocols on every batch of research compounds manufactured for laboratory release.

Every production lot undergoes comprehensive analytical evaluation in ISO 17025 accredited facilities:

• High-Performance Liquid Chromatography (HPLC): Verifies chemical purity levels exceeding 98.0%, confirming the absence of unreacted precursors or structural degradation products. • Mass Spectrometry (MS): Confirms exact molecular mass and identity against theoretical structure. • Endotoxin Testing (LAL Assay): Ensures endotoxin levels remain below strict laboratory limits (<0.05 EU/mg) to prevent non-specific immune activation in primary cell cultures and animal models. • Moisture Content Analysis: Karl Fischer titration ensures low residual moisture for maximum shelf-life stability.

Researchers can inspect and download verified independent laboratory certificates directly from our dedicated COA verification portal.

Selecting Fill Sizes: 5mg vs. 10mg Vial Configurations

Determining whether a 5mg or 10mg vial configuration is optimal depends heavily on experimental design, assay volume requirements, and reconstitution workflow:

• Select 5mg Vials: Ideal for pilot studies, single-plate assay runs, low-volume cell culture experiments, or protocols requiring frequent fresh reconstitution to minimize solution storage time. Explore our standard 5-Amino-1MQ 5mg product specification for small-scale applications.

• Select 10mg Vials: Optimal for multi-plate high-throughput screening, continuous multi-week animal study series, or institutional laboratories running parallel assay arms where preparing a single, large master stock solution reduces intra-assay variability.

For large-scale academic grants or institutional research facilities requiring custom bulk packaging or contract batch sizes, PX1 Research provides dedicated purchasing solutions via our wholesale lab portal.

Comparative Analysis: Metabolic & Performance Research Class

Within the broader catalog of bioenergetic and metabolic research targets, 5-Amino-1MQ occupies a distinct functional niche as a direct enzymatic inhibitor. To properly contextualize its mechanism within comparative study designs, researchers frequently contrast 5-Amino-1MQ with mitochondrial-derived peptides, growth hormone secretagogues, and lipolytic fragments.

For instance, while 5-Amino-1MQ targets cytosolic NNMT to elevate endogenous NAD+ salvage, MOTS-c operates as a mitochondrial-derived peptide that translocates to the nucleus under metabolic stress to regulate folate chemistry and AMPK activation. Similarly, growth hormone receptor agonists such as Tesamorelin promote metabolic substrate mobilization via upstream neuroendocrine signaling, whereas synthetic fragments like AOD-9604 act through targeted adipocyte lipolytic receptor pathways. Evaluating these complementary mechanisms allows researchers to construct robust multi-target experimental matrices.